Building on the proven performance of the GORE® EXCLUDER® Device family, the conformable stent graft and innovative delivery system offer new levels of control when you need it most.
Continuing the pattern of performance
Sub-study outcomes. One-year follow-up*,†
Sub-study outcomes. One-year follow-up*,†
Sub-study outcomes. One-year follow-up*,†
I am impressed with how well the device performed in the clinical study and appreciate the efforts of the investigators who contributed to this milestone.
– Robert Rhee, M.D., Chief of Vascular and Endovascular Surgery, Maimonides Medical Center, Brooklyn, New York , National Principal Investigator
* For these data points, a minimum of 66 patients were eligible for one year outcome analysis, meeting all follow-up requirements that included contrast enhanced CT’s. More than 66 patients were included in some data points, which can be confirmed in the Instructions for Use.
† 1-year follow-up. Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms. NLM Identifier: NCT02489539. Published July 3, 2015. Updated June 16, 2020. Accessed November 17, 2020. https://clinicaltrials.gov/ct2/show/NCT02489539
Featured Resources
Measurement Form with Anatomy
GORE® EXCLUDER® Conformable AAA Endoprosthesis, GORE® EXCLUDER® Iliac Branch Endoprosthesis, GORE® EXCLUDER® AAA Endoprosthesis
PDF, 324.91 KB
Wall Chart for the GORE(R) EXCLUDER(R) Conformable AAA Endoprosthesis with ACTIVE CONTROL System
Wall Chart for the GORE(R) EXCLUDER(R) Conformable AAA Endoprosthesis with ACTIVE CONTROL System
PDF, 1.47 MB
